Jeannet C. Bos
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Pneumonia and Respiratory Infections, Antibiotics Pharmacokinetics and Efficacy, COVID-19 Clinical Research Studies, Antibiotic Use and Resistance
Most-Cited Works
- → Convalescent Plasma for COVID-19. A randomized clinical trial(2020)239 cited
- → Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection(2021)158 cited
- → Frailty is associated with in-hospital mortality in older hospitalised COVID-19 patients in the Netherlands: the COVID-OLD study(2021)121 cited
- → COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study(2021)80 cited
- → Pharmacokinetics and pharmacodynamic target attainment of ceftriaxone in adult severely ill sub-Saharan African patients: a population pharmacokinetic modelling study(2018)36 cited
- Ribavirin in the treatment of severe acute respiratory syndrome (SARS).(2003)
- → Population Pharmacokinetics with Monte Carlo Simulations of Gentamicin in a Population of Severely Ill Adult Patients from Sub-Saharan Africa(2019)10 cited
- → Antimicrobial susceptibility of Streptococcus pneumoniae in adult patients with pneumococcal pneumonia in an urban hospital in Mozambique(2014)9 cited
- → Pharmacokinetics and Pharmacodynamic Target Attainment of Benzylpenicillin in an Adult Severely Ill Sub-Saharan African Patient Population(2017)7 cited
- → Effects of Potent Neutralizing Antibodies from Convalescent Plasma in Patients Hospitalized for Severe SARS-CoV-2 Infection.(2020)6 cited